GREENLANE HOLDINGS INC - A (GNLN)

US3953303019 - Common Stock

1.8  +0.01 (+0.56%)

After market: 1.84 +0.04 (+2.22%)

Fundamental Rating

2

Overall GNLN gets a fundamental rating of 2 out of 10. We evaluated GNLN against 15 industry peers in the Distributors industry. The financial health of GNLN is average, but there are quite some concerns on its profitability. GNLN is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year GNLN has reported negative net income.
In the past year GNLN has reported a negative cash flow from operations.
GNLN had negative earnings in each of the past 5 years.
GNLN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -60.57%, GNLN is doing worse than 92.31% of the companies in the same industry.
Looking at the Return On Equity, with a value of -326.79%, GNLN is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
ROA -60.57%
ROE -326.79%
ROIC N/A
ROA(3y)-58.48%
ROA(5y)-41.21%
ROE(3y)-143.88%
ROE(5y)-131.25%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Gross Margin value of 34.92%, GNLN is doing good in the industry, outperforming 69.23% of the companies in the same industry.
GNLN's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for GNLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.26%
GM growth 5Y6.44%

4

2. Health

2.1 Basic Checks

GNLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GNLN has less shares outstanding
Compared to 5 years ago, GNLN has less shares outstanding
GNLN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -11.93, we must say that GNLN is in the distress zone and has some risk of bankruptcy.
GNLN has a worse Altman-Z score (-11.93) than 92.31% of its industry peers.
There is no outstanding debt for GNLN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.93
ROIC/WACCN/A
WACC25.7%

2.3 Liquidity

A Current Ratio of 0.96 indicates that GNLN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.96, GNLN is doing worse than 92.31% of the companies in the same industry.
GNLN has a Quick Ratio of 0.96. This is a bad value and indicates that GNLN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.31, GNLN is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.96
Quick Ratio 0.31

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 72.04% over the past year.
The Revenue for GNLN has decreased by -68.83% in the past year. This is quite bad
The Revenue for GNLN have been decreasing by -18.24% on average. This is quite bad
EPS 1Y (TTM)72.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.8%
Revenue 1Y (TTM)-68.83%
Revenue growth 3Y-22.1%
Revenue growth 5Y-18.24%
Sales Q2Q%-86.49%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, GNLN will show a very strong growth in Revenue. The Revenue will grow by 51.19% on average per year.
EPS Next Y62.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.16%
Revenue Next 2Y51.19%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

GNLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GNLN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GNLN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GREENLANE HOLDINGS INC - A

NASDAQ:GNLN (11/22/2024, 8:00:00 PM)

After market: 1.84 +0.04 (+2.22%)

1.8

+0.01 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.24M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.57%
ROE -326.79%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 34.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.89
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.96
Quick Ratio 0.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)72.04%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y62.77%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-68.83%
Revenue growth 3Y-22.1%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y